- Infectious Diseases (e.g. sepsis, HIV, TB, hepatitis, other viral infections)
- Autoimmune and Inflammatory Disorders (e.g. diabetes, lupus, MS, fibrosis, asthma, inflammatory bowel disease, rheumatoid arthritis, etc.)
- Regenerative Therapies (e.g. transplantation, spinal cord injury, bone and cartilage repair etc.)
What Is ImmunoEngineering?
ImmunoEngineering is the application of engineering tools and principles to quantitatively study the immune system in health and disease and to develop new therapies or improve existing therapies by enhancing or modulating immune responses.
Who We Are
The Georgia Immunoengineering Consortium is a unique partnership between the Georgia Institute of Technology and Emory University that brings together engineers, chemists, physicists, computational scientists, immunologists and clinicians to collaboratively understand how the immune system works and find breakthrough solutions to improve the lives of patients suffering from cancer, infectious diseases, autoimmune and inflammatory disorders as well as those undergoing regenerative therapies. Read More >>
The mission of the Georgia Immunoengineering Consortium is to create breakthrough engineering tools, methods and solutions for personalized and predictive health-care in individuals with particular focus on the following three Grand Challenges:
- Ability to rapidly provide a comprehensive immunological status
- Ability to quantitatively predict immune function and
- Ability to enhance and modulate immune response